These results demonstrate an interaction between CRTAC1 and CFP at the nanomolar concentrations present in plasma and support the hypothesis that plasma CRTAC1 is consumed in severe COVID‐19 due to its interaction with CFP deposited to drive the alternate complement pathway. Here, CRTAC1 is linked to COVID-19.